We are live on ! Find out more
INGN icon

Inogen

130 hedge funds and large institutions have $176M invested in Inogen in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 53 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

462% more call options, than puts

Call options by funds: $2.3M | Put options by funds: $409K

10% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 20

2% more capital invested

Capital invested by funds: $172M → $176M (+$4.08M)

1% more funds holding

Funds holding: 129130 (+1)

0.58% more ownership

Funds ownership: 91.45%92.03% (+0.58%)

32% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 53

Holders
130
Holders Change
+1
Holders Change %
+0.78%
% of All Funds
1.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
22
Increased
36
Reduced
53
Closed
20
Calls
$2.3M
Puts
$409K
Net Calls
+$1.89M
Net Calls Change
+$1.31M

INGN Hedge Fund Activity: Q2 2024 in Review

130 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q2 2024, worth a combined $176M — up 2.4% from $172M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new INGN positions and 20 closed out — a net gain of 2 holders — while 36 added to existing stakes and 53 trimmed.

The largest buyer was Divisadero Street Capital Management, adding an estimated $15.8M. The largest seller was Morgan Stanley, cutting an estimated $5.03M.

  • 130 institutional investors held Inogen (INGN) as of Q2 2024, up from 129 in Q1 2024.
  • Funds reported $176M of Inogen stock for Q2 2024, up 2.4% quarter-over-quarter.
  • 22 funds opened new Inogen positions in Q2 2024 and 20 closed out, a net change of +2 holders.
  • The largest Inogen buyer in Q2 2024 was Divisadero Street Capital Management, an estimated $15.8M added.
  • The largest Inogen seller in Q2 2024 was Morgan Stanley, an estimated $5.03M sold.

Based on aggregated 13F filings for Q2 2024.